Abstract 2532: integrated therapeutic antibody development at the National Research Council of Canada

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1158/1538-7445.AM2012-2532
AuthorSearch for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleCancer Research
ISSN0008-5472
1538-7445
Volume72
Issue8 Supplement
Pages25322532
Abstract
Publication date
PublisherAmerican Association for Cancer Research
LanguageEnglish
Peer reviewedYes
NPARC number23001785
Export citationExport as RIS
Report a correctionReport a correction
Record identifier43e3adb3-7a37-4997-8810-9a01dd13295c
Record created2017-04-06
Record modified2017-04-06
Date modified: